Vertex receives USD 10 million from Aventis for new drugs targeting inflammatory diseases May 29, 2000
4,5-Dihydroisoxazole derivatives and their use as immunomodulators and antiproliferative agents May 23, 2000
Phenylalkanoic acid derivatives as alpha4 integrin inhibitors; use in immune, inflammatory disorders May 22, 2000
Synthesis and biological activity of new cell adhesion inhibitors described by Nihon Nohyaku May 22, 2000
RSS